Keyphrases
Patients with Heart Failure
100%
Out-of-pocket Expenditure
100%
Sacubitril-valsartan
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
85%
Patient Characteristics
28%
Receiving Care
28%
Angiotensin Receptor Blockers
28%
Geographic Variation
28%
Medicare Advantage
28%
Angiotensin-converting Enzyme Inhibitor (ACEi)
28%
Cardiologists
28%
International Classification of Diseases
14%
Odds Ratio
14%
Adult Patients
14%
Primary Care Physicians
14%
National Health Insurance
14%
Current Guidelines
14%
Beta-blockers
14%
Associated Costs
14%
Real-world Use
14%
Low Uptake
14%
Heart Disease Diagnosis
14%
ICD-10 Diagnosis
14%
Commercial Insurance
14%
Tenth Revision
14%
Optum
14%
Outpatient Encounter
14%
Commercially Insured
14%
Insurance Claims Data
14%
Pharmacology, Toxicology and Pharmaceutical Science
Valsartan/Sacubitril
100%
Heart Failure
100%
Heart Failure with Reduced Ejection Fraction
85%
Dipeptidyl Carboxypeptidase Inhibitor
28%
Angiotensin Receptor Antagonist
28%
ICD-10
28%
Retrospective Study
14%